nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1B1—Estradiol—osteoporosis	0.0716	0.114	CbGbCtD
Lansoprazole—CYP1A1—Cholecalciferol—osteoporosis	0.039	0.0622	CbGbCtD
Lansoprazole—ABCG2—Conjugated Estrogens—osteoporosis	0.0388	0.0619	CbGbCtD
Lansoprazole—ABCG2—Estradiol—osteoporosis	0.034	0.0543	CbGbCtD
Lansoprazole—CYP1A2—Estropipate—osteoporosis	0.0338	0.0539	CbGbCtD
Lansoprazole—CYP1A1—Estradiol—osteoporosis	0.0314	0.0501	CbGbCtD
Lansoprazole—CYP2C9—Estropipate—osteoporosis	0.0305	0.0486	CbGbCtD
Lansoprazole—CYP2C8—Raloxifene—osteoporosis	0.0291	0.0465	CbGbCtD
Lansoprazole—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0281	0.0449	CbGbCtD
Lansoprazole—CYP2C8—Cholecalciferol—osteoporosis	0.0225	0.0359	CbGbCtD
Lansoprazole—ABCB1—Ethinyl Estradiol—osteoporosis	0.019	0.0304	CbGbCtD
Lansoprazole—CYP2C19—Cholecalciferol—osteoporosis	0.0189	0.0301	CbGbCtD
Lansoprazole—CYP2C8—Estradiol—osteoporosis	0.0181	0.0289	CbGbCtD
Lansoprazole—CYP3A4—Estropipate—osteoporosis	0.0177	0.0283	CbGbCtD
Lansoprazole—CYP3A4—Calcitriol—osteoporosis	0.0177	0.0283	CbGbCtD
Lansoprazole—CYP1A2—Conjugated Estrogens—osteoporosis	0.016	0.0255	CbGbCtD
Lansoprazole—CYP2C9—Cholecalciferol—osteoporosis	0.0157	0.025	CbGbCtD
Lansoprazole—CYP2C19—Estradiol—osteoporosis	0.0152	0.0243	CbGbCtD
Lansoprazole—CYP2D6—Cholecalciferol—osteoporosis	0.0143	0.0229	CbGbCtD
Lansoprazole—CYP3A4—Ergocalciferol—osteoporosis	0.0142	0.0226	CbGbCtD
Lansoprazole—CYP1A2—Estradiol—osteoporosis	0.014	0.0224	CbGbCtD
Lansoprazole—ABCB1—Conjugated Estrogens—osteoporosis	0.014	0.0223	CbGbCtD
Lansoprazole—CYP2C9—Estradiol—osteoporosis	0.0126	0.0202	CbGbCtD
Lansoprazole—ABCB1—Estradiol—osteoporosis	0.0123	0.0196	CbGbCtD
Lansoprazole—CYP3A4—Raloxifene—osteoporosis	0.0118	0.0189	CbGbCtD
Lansoprazole—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0114	0.0182	CbGbCtD
Lansoprazole—CYP3A4—Cholecalciferol—osteoporosis	0.00912	0.0146	CbGbCtD
Lansoprazole—CYP3A4—Conjugated Estrogens—osteoporosis	0.00837	0.0134	CbGbCtD
Lansoprazole—CYP3A4—Estradiol—osteoporosis	0.00735	0.0117	CbGbCtD
Lansoprazole—Fatigue—Ethinyl Estradiol—osteoporosis	0.000102	0.00034	CcSEcCtD
Lansoprazole—Pruritus—Alendronate—osteoporosis	0.000102	0.000339	CcSEcCtD
Lansoprazole—Dyspepsia—Risedronate—osteoporosis	0.000101	0.000338	CcSEcCtD
Lansoprazole—Eye disorder—Estradiol—osteoporosis	0.000101	0.000338	CcSEcCtD
Lansoprazole—Tinnitus—Estradiol—osteoporosis	0.000101	0.000337	CcSEcCtD
Lansoprazole—Constipation—Ethinyl Estradiol—osteoporosis	0.000101	0.000337	CcSEcCtD
Lansoprazole—Confusional state—Zoledronate—osteoporosis	0.000101	0.000336	CcSEcCtD
Lansoprazole—Hypersensitivity—Calcitriol—osteoporosis	0.000101	0.000336	CcSEcCtD
Lansoprazole—Cardiac disorder—Estradiol—osteoporosis	0.000101	0.000336	CcSEcCtD
Lansoprazole—Arthralgia—Conjugated Estrogens—osteoporosis	0.0001	0.000335	CcSEcCtD
Lansoprazole—Chest pain—Conjugated Estrogens—osteoporosis	0.0001	0.000335	CcSEcCtD
Lansoprazole—Myalgia—Conjugated Estrogens—osteoporosis	0.0001	0.000335	CcSEcCtD
Lansoprazole—Asthenia—Ibandronate—osteoporosis	0.0001	0.000334	CcSEcCtD
Lansoprazole—Anxiety—Conjugated Estrogens—osteoporosis	0.0001	0.000334	CcSEcCtD
Lansoprazole—Nausea—Etidronic acid—osteoporosis	0.0001	0.000334	CcSEcCtD
Lansoprazole—Anaphylactic shock—Zoledronate—osteoporosis	0.0001	0.000333	CcSEcCtD
Lansoprazole—Oedema—Zoledronate—osteoporosis	0.0001	0.000333	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.98e-05	0.000333	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.98e-05	0.000333	CcSEcCtD
Lansoprazole—Diarrhoea—Estropipate—osteoporosis	9.97e-05	0.000332	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Risedronate—osteoporosis	9.95e-05	0.000331	CcSEcCtD
Lansoprazole—Infection—Zoledronate—osteoporosis	9.94e-05	0.000331	CcSEcCtD
Lansoprazole—Fatigue—Risedronate—osteoporosis	9.93e-05	0.000331	CcSEcCtD
Lansoprazole—Insomnia—Pamidronate—osteoporosis	9.9e-05	0.00033	CcSEcCtD
Lansoprazole—Pruritus—Ibandronate—osteoporosis	9.89e-05	0.00033	CcSEcCtD
Lansoprazole—Constipation—Risedronate—osteoporosis	9.85e-05	0.000328	CcSEcCtD
Lansoprazole—Pain—Risedronate—osteoporosis	9.85e-05	0.000328	CcSEcCtD
Lansoprazole—Angiopathy—Estradiol—osteoporosis	9.84e-05	0.000328	CcSEcCtD
Lansoprazole—Shock—Zoledronate—osteoporosis	9.84e-05	0.000328	CcSEcCtD
Lansoprazole—Paraesthesia—Pamidronate—osteoporosis	9.83e-05	0.000328	CcSEcCtD
Lansoprazole—Diarrhoea—Alendronate—osteoporosis	9.82e-05	0.000327	CcSEcCtD
Lansoprazole—Asthenia—Calcitriol—osteoporosis	9.82e-05	0.000327	CcSEcCtD
Lansoprazole—Nervous system disorder—Zoledronate—osteoporosis	9.81e-05	0.000327	CcSEcCtD
Lansoprazole—Immune system disorder—Estradiol—osteoporosis	9.8e-05	0.000327	CcSEcCtD
Lansoprazole—Thrombocytopenia—Zoledronate—osteoporosis	9.79e-05	0.000326	CcSEcCtD
Lansoprazole—Mediastinal disorder—Estradiol—osteoporosis	9.78e-05	0.000326	CcSEcCtD
Lansoprazole—Dyspnoea—Pamidronate—osteoporosis	9.76e-05	0.000325	CcSEcCtD
Lansoprazole—Tachycardia—Zoledronate—osteoporosis	9.76e-05	0.000325	CcSEcCtD
Lansoprazole—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.74e-05	0.000325	CcSEcCtD
Lansoprazole—Chills—Estradiol—osteoporosis	9.74e-05	0.000324	CcSEcCtD
Lansoprazole—Somnolence—Pamidronate—osteoporosis	9.74e-05	0.000324	CcSEcCtD
Lansoprazole—Skin disorder—Zoledronate—osteoporosis	9.72e-05	0.000324	CcSEcCtD
Lansoprazole—Pruritus—Calcitriol—osteoporosis	9.68e-05	0.000323	CcSEcCtD
Lansoprazole—Hyperhidrosis—Zoledronate—osteoporosis	9.67e-05	0.000322	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.66e-05	0.000322	CcSEcCtD
Lansoprazole—Diarrhoea—Raloxifene—osteoporosis	9.66e-05	0.000322	CcSEcCtD
Lansoprazole—Dyspepsia—Pamidronate—osteoporosis	9.64e-05	0.000321	CcSEcCtD
Lansoprazole—Dizziness—Estropipate—osteoporosis	9.64e-05	0.000321	CcSEcCtD
Lansoprazole—Anaphylactic shock—Conjugated Estrogens—osteoporosis	9.63e-05	0.000321	CcSEcCtD
Lansoprazole—Oedema—Conjugated Estrogens—osteoporosis	9.63e-05	0.000321	CcSEcCtD
Lansoprazole—Alopecia—Estradiol—osteoporosis	9.59e-05	0.00032	CcSEcCtD
Lansoprazole—Infection—Conjugated Estrogens—osteoporosis	9.57e-05	0.000319	CcSEcCtD
Lansoprazole—Diarrhoea—Ibandronate—osteoporosis	9.56e-05	0.000319	CcSEcCtD
Lansoprazole—Anorexia—Zoledronate—osteoporosis	9.54e-05	0.000318	CcSEcCtD
Lansoprazole—Decreased appetite—Pamidronate—osteoporosis	9.52e-05	0.000317	CcSEcCtD
Lansoprazole—Mental disorder—Estradiol—osteoporosis	9.51e-05	0.000317	CcSEcCtD
Lansoprazole—Dizziness—Alendronate—osteoporosis	9.49e-05	0.000316	CcSEcCtD
Lansoprazole—Shock—Conjugated Estrogens—osteoporosis	9.48e-05	0.000316	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Pamidronate—osteoporosis	9.45e-05	0.000315	CcSEcCtD
Lansoprazole—Nervous system disorder—Conjugated Estrogens—osteoporosis	9.45e-05	0.000315	CcSEcCtD
Lansoprazole—Erythema—Estradiol—osteoporosis	9.45e-05	0.000315	CcSEcCtD
Lansoprazole—Malnutrition—Estradiol—osteoporosis	9.45e-05	0.000315	CcSEcCtD
Lansoprazole—Fatigue—Pamidronate—osteoporosis	9.44e-05	0.000315	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Risedronate—osteoporosis	9.42e-05	0.000314	CcSEcCtD
Lansoprazole—Tachycardia—Conjugated Estrogens—osteoporosis	9.4e-05	0.000313	CcSEcCtD
Lansoprazole—Urticaria—Ethinyl Estradiol—osteoporosis	9.39e-05	0.000313	CcSEcCtD
Lansoprazole—Constipation—Pamidronate—osteoporosis	9.36e-05	0.000312	CcSEcCtD
Lansoprazole—Pain—Pamidronate—osteoporosis	9.36e-05	0.000312	CcSEcCtD
Lansoprazole—Diarrhoea—Calcitriol—osteoporosis	9.36e-05	0.000312	CcSEcCtD
Lansoprazole—Skin disorder—Conjugated Estrogens—osteoporosis	9.36e-05	0.000312	CcSEcCtD
Lansoprazole—Hypotension—Zoledronate—osteoporosis	9.35e-05	0.000312	CcSEcCtD
Lansoprazole—Abdominal pain—Ethinyl Estradiol—osteoporosis	9.34e-05	0.000311	CcSEcCtD
Lansoprazole—Body temperature increased—Ethinyl Estradiol—osteoporosis	9.34e-05	0.000311	CcSEcCtD
Lansoprazole—Dizziness—Raloxifene—osteoporosis	9.34e-05	0.000311	CcSEcCtD
Lansoprazole—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.31e-05	0.00031	CcSEcCtD
Lansoprazole—Flatulence—Estradiol—osteoporosis	9.31e-05	0.00031	CcSEcCtD
Lansoprazole—Tension—Estradiol—osteoporosis	9.27e-05	0.000309	CcSEcCtD
Lansoprazole—Vomiting—Estropipate—osteoporosis	9.27e-05	0.000309	CcSEcCtD
Lansoprazole—Dysgeusia—Estradiol—osteoporosis	9.25e-05	0.000308	CcSEcCtD
Lansoprazole—Dizziness—Ibandronate—osteoporosis	9.24e-05	0.000308	CcSEcCtD
Lansoprazole—Rash—Estropipate—osteoporosis	9.19e-05	0.000306	CcSEcCtD
Lansoprazole—Dermatitis—Estropipate—osteoporosis	9.18e-05	0.000306	CcSEcCtD
Lansoprazole—Anorexia—Conjugated Estrogens—osteoporosis	9.18e-05	0.000306	CcSEcCtD
Lansoprazole—Nervousness—Estradiol—osteoporosis	9.17e-05	0.000306	CcSEcCtD
Lansoprazole—Urticaria—Risedronate—osteoporosis	9.15e-05	0.000305	CcSEcCtD
Lansoprazole—Back pain—Estradiol—osteoporosis	9.14e-05	0.000305	CcSEcCtD
Lansoprazole—Headache—Estropipate—osteoporosis	9.13e-05	0.000304	CcSEcCtD
Lansoprazole—Vomiting—Alendronate—osteoporosis	9.13e-05	0.000304	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Zoledronate—osteoporosis	9.11e-05	0.000304	CcSEcCtD
Lansoprazole—Abdominal pain—Risedronate—osteoporosis	9.11e-05	0.000304	CcSEcCtD
Lansoprazole—Body temperature increased—Risedronate—osteoporosis	9.11e-05	0.000304	CcSEcCtD
Lansoprazole—Muscle spasms—Estradiol—osteoporosis	9.08e-05	0.000303	CcSEcCtD
Lansoprazole—Rash—Alendronate—osteoporosis	9.05e-05	0.000302	CcSEcCtD
Lansoprazole—Insomnia—Zoledronate—osteoporosis	9.05e-05	0.000302	CcSEcCtD
Lansoprazole—Dermatitis—Alendronate—osteoporosis	9.04e-05	0.000301	CcSEcCtD
Lansoprazole—Feeling abnormal—Pamidronate—osteoporosis	9.02e-05	0.000301	CcSEcCtD
Lansoprazole—Hypotension—Conjugated Estrogens—osteoporosis	9e-05	0.0003	CcSEcCtD
Lansoprazole—Headache—Alendronate—osteoporosis	8.99e-05	0.0003	CcSEcCtD
Lansoprazole—Paraesthesia—Zoledronate—osteoporosis	8.98e-05	0.000299	CcSEcCtD
Lansoprazole—Vomiting—Raloxifene—osteoporosis	8.98e-05	0.000299	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Pamidronate—osteoporosis	8.95e-05	0.000298	CcSEcCtD
Lansoprazole—Dyspnoea—Zoledronate—osteoporosis	8.92e-05	0.000297	CcSEcCtD
Lansoprazole—Rash—Raloxifene—osteoporosis	8.9e-05	0.000297	CcSEcCtD
Lansoprazole—Dermatitis—Raloxifene—osteoporosis	8.89e-05	0.000296	CcSEcCtD
Lansoprazole—Somnolence—Zoledronate—osteoporosis	8.89e-05	0.000296	CcSEcCtD
Lansoprazole—Vomiting—Ibandronate—osteoporosis	8.89e-05	0.000296	CcSEcCtD
Lansoprazole—Tremor—Estradiol—osteoporosis	8.85e-05	0.000295	CcSEcCtD
Lansoprazole—Headache—Raloxifene—osteoporosis	8.85e-05	0.000295	CcSEcCtD
Lansoprazole—Rash—Ibandronate—osteoporosis	8.81e-05	0.000294	CcSEcCtD
Lansoprazole—Dermatitis—Ibandronate—osteoporosis	8.81e-05	0.000293	CcSEcCtD
Lansoprazole—Dyspepsia—Zoledronate—osteoporosis	8.81e-05	0.000293	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.78e-05	0.000292	CcSEcCtD
Lansoprazole—Ill-defined disorder—Estradiol—osteoporosis	8.76e-05	0.000292	CcSEcCtD
Lansoprazole—Headache—Ibandronate—osteoporosis	8.76e-05	0.000292	CcSEcCtD
Lansoprazole—Insomnia—Conjugated Estrogens—osteoporosis	8.71e-05	0.00029	CcSEcCtD
Lansoprazole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.71e-05	0.00029	CcSEcCtD
Lansoprazole—Vomiting—Calcitriol—osteoporosis	8.7e-05	0.00029	CcSEcCtD
Lansoprazole—Decreased appetite—Zoledronate—osteoporosis	8.7e-05	0.00029	CcSEcCtD
Lansoprazole—Agitation—Estradiol—osteoporosis	8.68e-05	0.000289	CcSEcCtD
Lansoprazole—Nausea—Estropipate—osteoporosis	8.66e-05	0.000289	CcSEcCtD
Lansoprazole—Abdominal pain—Pamidronate—osteoporosis	8.66e-05	0.000289	CcSEcCtD
Lansoprazole—Body temperature increased—Pamidronate—osteoporosis	8.66e-05	0.000289	CcSEcCtD
Lansoprazole—Paraesthesia—Conjugated Estrogens—osteoporosis	8.65e-05	0.000288	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Zoledronate—osteoporosis	8.64e-05	0.000288	CcSEcCtD
Lansoprazole—Angioedema—Estradiol—osteoporosis	8.63e-05	0.000288	CcSEcCtD
Lansoprazole—Rash—Calcitriol—osteoporosis	8.63e-05	0.000288	CcSEcCtD
Lansoprazole—Fatigue—Zoledronate—osteoporosis	8.62e-05	0.000287	CcSEcCtD
Lansoprazole—Dermatitis—Calcitriol—osteoporosis	8.62e-05	0.000287	CcSEcCtD
Lansoprazole—Dyspnoea—Conjugated Estrogens—osteoporosis	8.59e-05	0.000286	CcSEcCtD
Lansoprazole—Headache—Calcitriol—osteoporosis	8.57e-05	0.000286	CcSEcCtD
Lansoprazole—Somnolence—Conjugated Estrogens—osteoporosis	8.56e-05	0.000285	CcSEcCtD
Lansoprazole—Pain—Zoledronate—osteoporosis	8.55e-05	0.000285	CcSEcCtD
Lansoprazole—Constipation—Zoledronate—osteoporosis	8.55e-05	0.000285	CcSEcCtD
Lansoprazole—Nausea—Alendronate—osteoporosis	8.53e-05	0.000284	CcSEcCtD
Lansoprazole—Malaise—Estradiol—osteoporosis	8.52e-05	0.000284	CcSEcCtD
Lansoprazole—Hypersensitivity—Risedronate—osteoporosis	8.49e-05	0.000283	CcSEcCtD
Lansoprazole—Vertigo—Estradiol—osteoporosis	8.49e-05	0.000283	CcSEcCtD
Lansoprazole—Dyspepsia—Conjugated Estrogens—osteoporosis	8.48e-05	0.000283	CcSEcCtD
Lansoprazole—Asthenia—Ethinyl Estradiol—osteoporosis	8.48e-05	0.000283	CcSEcCtD
Lansoprazole—Syncope—Estradiol—osteoporosis	8.47e-05	0.000282	CcSEcCtD
Lansoprazole—Nausea—Raloxifene—osteoporosis	8.39e-05	0.00028	CcSEcCtD
Lansoprazole—Decreased appetite—Conjugated Estrogens—osteoporosis	8.37e-05	0.000279	CcSEcCtD
Lansoprazole—Pruritus—Ethinyl Estradiol—osteoporosis	8.36e-05	0.000279	CcSEcCtD
Lansoprazole—Palpitations—Estradiol—osteoporosis	8.35e-05	0.000278	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	8.32e-05	0.000277	CcSEcCtD
Lansoprazole—Fatigue—Conjugated Estrogens—osteoporosis	8.3e-05	0.000277	CcSEcCtD
Lansoprazole—Nausea—Ibandronate—osteoporosis	8.3e-05	0.000277	CcSEcCtD
Lansoprazole—Loss of consciousness—Estradiol—osteoporosis	8.3e-05	0.000277	CcSEcCtD
Lansoprazole—Asthenia—Risedronate—osteoporosis	8.27e-05	0.000275	CcSEcCtD
Lansoprazole—Feeling abnormal—Zoledronate—osteoporosis	8.24e-05	0.000275	CcSEcCtD
Lansoprazole—Cough—Estradiol—osteoporosis	8.24e-05	0.000275	CcSEcCtD
Lansoprazole—Pain—Conjugated Estrogens—osteoporosis	8.24e-05	0.000275	CcSEcCtD
Lansoprazole—Constipation—Conjugated Estrogens—osteoporosis	8.24e-05	0.000275	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Zoledronate—osteoporosis	8.18e-05	0.000273	CcSEcCtD
Lansoprazole—Hypertension—Estradiol—osteoporosis	8.15e-05	0.000272	CcSEcCtD
Lansoprazole—Pruritus—Risedronate—osteoporosis	8.15e-05	0.000272	CcSEcCtD
Lansoprazole—Nausea—Calcitriol—osteoporosis	8.13e-05	0.000271	CcSEcCtD
Lansoprazole—Diarrhoea—Ethinyl Estradiol—osteoporosis	8.08e-05	0.000269	CcSEcCtD
Lansoprazole—Hypersensitivity—Pamidronate—osteoporosis	8.07e-05	0.000269	CcSEcCtD
Lansoprazole—Myalgia—Estradiol—osteoporosis	8.04e-05	0.000268	CcSEcCtD
Lansoprazole—Arthralgia—Estradiol—osteoporosis	8.04e-05	0.000268	CcSEcCtD
Lansoprazole—Chest pain—Estradiol—osteoporosis	8.04e-05	0.000268	CcSEcCtD
Lansoprazole—Anxiety—Estradiol—osteoporosis	8.01e-05	0.000267	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.99e-05	0.000266	CcSEcCtD
Lansoprazole—Urticaria—Zoledronate—osteoporosis	7.95e-05	0.000265	CcSEcCtD
Lansoprazole—Discomfort—Estradiol—osteoporosis	7.95e-05	0.000265	CcSEcCtD
Lansoprazole—Abdominal pain—Zoledronate—osteoporosis	7.91e-05	0.000264	CcSEcCtD
Lansoprazole—Body temperature increased—Zoledronate—osteoporosis	7.91e-05	0.000264	CcSEcCtD
Lansoprazole—Diarrhoea—Risedronate—osteoporosis	7.88e-05	0.000263	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.88e-05	0.000262	CcSEcCtD
Lansoprazole—Dry mouth—Estradiol—osteoporosis	7.86e-05	0.000262	CcSEcCtD
Lansoprazole—Asthenia—Pamidronate—osteoporosis	7.86e-05	0.000262	CcSEcCtD
Lansoprazole—Dizziness—Ethinyl Estradiol—osteoporosis	7.81e-05	0.00026	CcSEcCtD
Lansoprazole—Confusional state—Estradiol—osteoporosis	7.77e-05	0.000259	CcSEcCtD
Lansoprazole—Pruritus—Pamidronate—osteoporosis	7.75e-05	0.000258	CcSEcCtD
Lansoprazole—Anaphylactic shock—Estradiol—osteoporosis	7.71e-05	0.000257	CcSEcCtD
Lansoprazole—Oedema—Estradiol—osteoporosis	7.71e-05	0.000257	CcSEcCtD
Lansoprazole—Infection—Estradiol—osteoporosis	7.66e-05	0.000255	CcSEcCtD
Lansoprazole—Urticaria—Conjugated Estrogens—osteoporosis	7.65e-05	0.000255	CcSEcCtD
Lansoprazole—Dizziness—Risedronate—osteoporosis	7.62e-05	0.000254	CcSEcCtD
Lansoprazole—Abdominal pain—Conjugated Estrogens—osteoporosis	7.61e-05	0.000254	CcSEcCtD
Lansoprazole—Body temperature increased—Conjugated Estrogens—osteoporosis	7.61e-05	0.000254	CcSEcCtD
Lansoprazole—Shock—Estradiol—osteoporosis	7.58e-05	0.000253	CcSEcCtD
Lansoprazole—Nervous system disorder—Estradiol—osteoporosis	7.56e-05	0.000252	CcSEcCtD
Lansoprazole—Tachycardia—Estradiol—osteoporosis	7.52e-05	0.000251	CcSEcCtD
Lansoprazole—Vomiting—Ethinyl Estradiol—osteoporosis	7.51e-05	0.00025	CcSEcCtD
Lansoprazole—Diarrhoea—Pamidronate—osteoporosis	7.49e-05	0.00025	CcSEcCtD
Lansoprazole—Skin disorder—Estradiol—osteoporosis	7.49e-05	0.00025	CcSEcCtD
Lansoprazole—Hyperhidrosis—Estradiol—osteoporosis	7.45e-05	0.000248	CcSEcCtD
Lansoprazole—Rash—Ethinyl Estradiol—osteoporosis	7.45e-05	0.000248	CcSEcCtD
Lansoprazole—Dermatitis—Ethinyl Estradiol—osteoporosis	7.44e-05	0.000248	CcSEcCtD
Lansoprazole—Headache—Ethinyl Estradiol—osteoporosis	7.4e-05	0.000247	CcSEcCtD
Lansoprazole—Hypersensitivity—Zoledronate—osteoporosis	7.37e-05	0.000246	CcSEcCtD
Lansoprazole—Vomiting—Risedronate—osteoporosis	7.32e-05	0.000244	CcSEcCtD
Lansoprazole—Rash—Risedronate—osteoporosis	7.26e-05	0.000242	CcSEcCtD
Lansoprazole—Dermatitis—Risedronate—osteoporosis	7.26e-05	0.000242	CcSEcCtD
Lansoprazole—Dizziness—Pamidronate—osteoporosis	7.24e-05	0.000241	CcSEcCtD
Lansoprazole—Headache—Risedronate—osteoporosis	7.22e-05	0.000241	CcSEcCtD
Lansoprazole—Asthenia—Zoledronate—osteoporosis	7.18e-05	0.000239	CcSEcCtD
Lansoprazole—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.1e-05	0.000237	CcSEcCtD
Lansoprazole—Pruritus—Zoledronate—osteoporosis	7.08e-05	0.000236	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Estradiol—osteoporosis	7.02e-05	0.000234	CcSEcCtD
Lansoprazole—Nausea—Ethinyl Estradiol—osteoporosis	7.02e-05	0.000234	CcSEcCtD
Lansoprazole—Insomnia—Estradiol—osteoporosis	6.97e-05	0.000232	CcSEcCtD
Lansoprazole—Vomiting—Pamidronate—osteoporosis	6.96e-05	0.000232	CcSEcCtD
Lansoprazole—Paraesthesia—Estradiol—osteoporosis	6.92e-05	0.000231	CcSEcCtD
Lansoprazole—Asthenia—Conjugated Estrogens—osteoporosis	6.91e-05	0.00023	CcSEcCtD
Lansoprazole—Rash—Pamidronate—osteoporosis	6.9e-05	0.00023	CcSEcCtD
Lansoprazole—Dermatitis—Pamidronate—osteoporosis	6.9e-05	0.00023	CcSEcCtD
Lansoprazole—Dyspnoea—Estradiol—osteoporosis	6.87e-05	0.000229	CcSEcCtD
Lansoprazole—Headache—Pamidronate—osteoporosis	6.86e-05	0.000229	CcSEcCtD
Lansoprazole—Somnolence—Estradiol—osteoporosis	6.85e-05	0.000228	CcSEcCtD
Lansoprazole—Diarrhoea—Zoledronate—osteoporosis	6.84e-05	0.000228	CcSEcCtD
Lansoprazole—Nausea—Risedronate—osteoporosis	6.84e-05	0.000228	CcSEcCtD
Lansoprazole—Pruritus—Conjugated Estrogens—osteoporosis	6.81e-05	0.000227	CcSEcCtD
Lansoprazole—Dyspepsia—Estradiol—osteoporosis	6.79e-05	0.000226	CcSEcCtD
Lansoprazole—Decreased appetite—Estradiol—osteoporosis	6.7e-05	0.000223	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Estradiol—osteoporosis	6.66e-05	0.000222	CcSEcCtD
Lansoprazole—Fatigue—Estradiol—osteoporosis	6.65e-05	0.000222	CcSEcCtD
Lansoprazole—Dizziness—Zoledronate—osteoporosis	6.61e-05	0.00022	CcSEcCtD
Lansoprazole—Pain—Estradiol—osteoporosis	6.59e-05	0.00022	CcSEcCtD
Lansoprazole—Constipation—Estradiol—osteoporosis	6.59e-05	0.00022	CcSEcCtD
Lansoprazole—Diarrhoea—Conjugated Estrogens—osteoporosis	6.59e-05	0.00022	CcSEcCtD
Lansoprazole—Nausea—Pamidronate—osteoporosis	6.5e-05	0.000217	CcSEcCtD
Lansoprazole—Dizziness—Conjugated Estrogens—osteoporosis	6.37e-05	0.000212	CcSEcCtD
Lansoprazole—Vomiting—Zoledronate—osteoporosis	6.36e-05	0.000212	CcSEcCtD
Lansoprazole—Feeling abnormal—Estradiol—osteoporosis	6.35e-05	0.000212	CcSEcCtD
Lansoprazole—Rash—Zoledronate—osteoporosis	6.31e-05	0.00021	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Estradiol—osteoporosis	6.3e-05	0.00021	CcSEcCtD
Lansoprazole—Dermatitis—Zoledronate—osteoporosis	6.3e-05	0.00021	CcSEcCtD
Lansoprazole—Headache—Zoledronate—osteoporosis	6.27e-05	0.000209	CcSEcCtD
Lansoprazole—Vomiting—Conjugated Estrogens—osteoporosis	6.12e-05	0.000204	CcSEcCtD
Lansoprazole—Urticaria—Estradiol—osteoporosis	6.12e-05	0.000204	CcSEcCtD
Lansoprazole—Body temperature increased—Estradiol—osteoporosis	6.09e-05	0.000203	CcSEcCtD
Lansoprazole—Abdominal pain—Estradiol—osteoporosis	6.09e-05	0.000203	CcSEcCtD
Lansoprazole—Rash—Conjugated Estrogens—osteoporosis	6.07e-05	0.000202	CcSEcCtD
Lansoprazole—Dermatitis—Conjugated Estrogens—osteoporosis	6.07e-05	0.000202	CcSEcCtD
Lansoprazole—Headache—Conjugated Estrogens—osteoporosis	6.03e-05	0.000201	CcSEcCtD
Lansoprazole—Nausea—Zoledronate—osteoporosis	5.94e-05	0.000198	CcSEcCtD
Lansoprazole—Nausea—Conjugated Estrogens—osteoporosis	5.72e-05	0.000191	CcSEcCtD
Lansoprazole—Hypersensitivity—Estradiol—osteoporosis	5.68e-05	0.000189	CcSEcCtD
Lansoprazole—Asthenia—Estradiol—osteoporosis	5.53e-05	0.000184	CcSEcCtD
Lansoprazole—Pruritus—Estradiol—osteoporosis	5.45e-05	0.000182	CcSEcCtD
Lansoprazole—Diarrhoea—Estradiol—osteoporosis	5.27e-05	0.000176	CcSEcCtD
Lansoprazole—Dizziness—Estradiol—osteoporosis	5.1e-05	0.00017	CcSEcCtD
Lansoprazole—Vomiting—Estradiol—osteoporosis	4.9e-05	0.000163	CcSEcCtD
Lansoprazole—Rash—Estradiol—osteoporosis	4.86e-05	0.000162	CcSEcCtD
Lansoprazole—Dermatitis—Estradiol—osteoporosis	4.86e-05	0.000162	CcSEcCtD
Lansoprazole—Headache—Estradiol—osteoporosis	4.83e-05	0.000161	CcSEcCtD
Lansoprazole—Nausea—Estradiol—osteoporosis	4.58e-05	0.000153	CcSEcCtD
Lansoprazole—ABCG2—Metabolism—CYP27A1—osteoporosis	3.21e-05	0.000437	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—TPI1—osteoporosis	3.19e-05	0.000435	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ENO1—osteoporosis	3.14e-05	0.000428	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ACP5—osteoporosis	3.12e-05	0.000425	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.11e-05	0.000424	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PSMA2—osteoporosis	3.1e-05	0.000422	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PSMA5—osteoporosis	3.1e-05	0.000422	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—FDPS—osteoporosis	3.09e-05	0.000422	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PKM—osteoporosis	3.09e-05	0.000422	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.09e-05	0.000422	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PKM—osteoporosis	3.02e-05	0.000412	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—FDPS—osteoporosis	3.02e-05	0.000412	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—POMC—osteoporosis	3.02e-05	0.000411	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PNP—osteoporosis	3.01e-05	0.00041	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ATIC—osteoporosis	3.01e-05	0.00041	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—P4HB—osteoporosis	3e-05	0.000409	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—POMC—osteoporosis	2.99e-05	0.000408	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GAPDH—osteoporosis	2.94e-05	0.000401	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.94e-05	0.000401	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPD2—osteoporosis	2.93e-05	0.0004	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PGLS—osteoporosis	2.93e-05	0.0004	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—TPI1—osteoporosis	2.9e-05	0.000395	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP19A1—osteoporosis	2.87e-05	0.000392	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—RAP1A—osteoporosis	2.87e-05	0.000391	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PGLS—osteoporosis	2.86e-05	0.00039	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPD2—osteoporosis	2.86e-05	0.00039	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PKM—osteoporosis	2.85e-05	0.000388	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—FDPS—osteoporosis	2.85e-05	0.000388	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.83e-05	0.000386	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PKM—osteoporosis	2.82e-05	0.000385	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—FDPS—osteoporosis	2.82e-05	0.000385	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CA2—osteoporosis	2.79e-05	0.00038	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—OXCT1—osteoporosis	2.79e-05	0.00038	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—P4HB—osteoporosis	2.73e-05	0.000372	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MGLL—osteoporosis	2.72e-05	0.00037	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PGLS—osteoporosis	2.7e-05	0.000368	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPD2—osteoporosis	2.7e-05	0.000368	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PNP—osteoporosis	2.68e-05	0.000366	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ATIC—osteoporosis	2.68e-05	0.000366	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GAPDH—osteoporosis	2.68e-05	0.000365	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PGLS—osteoporosis	2.67e-05	0.000365	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPD2—osteoporosis	2.67e-05	0.000365	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.64e-05	0.00036	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ATIC—osteoporosis	2.62e-05	0.000357	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PNP—osteoporosis	2.62e-05	0.000357	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—RAP1A—osteoporosis	2.61e-05	0.000355	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.56e-05	0.000349	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—POMC—osteoporosis	2.56e-05	0.000348	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—OXCT1—osteoporosis	2.56e-05	0.000348	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CA2—osteoporosis	2.56e-05	0.000348	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP19A1—osteoporosis	2.51e-05	0.000342	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.5e-05	0.000341	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MGLL—osteoporosis	2.49e-05	0.000339	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PNP—osteoporosis	2.47e-05	0.000336	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ATIC—osteoporosis	2.47e-05	0.000336	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ATIC—osteoporosis	2.45e-05	0.000333	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PNP—osteoporosis	2.45e-05	0.000333	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—FDPS—osteoporosis	2.41e-05	0.000329	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PKM—osteoporosis	2.41e-05	0.000329	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ADCY5—osteoporosis	2.35e-05	0.00032	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.35e-05	0.00032	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GPX1—osteoporosis	2.34e-05	0.000319	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ENO1—osteoporosis	2.32e-05	0.000316	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—IDH2—osteoporosis	2.31e-05	0.000315	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPD2—osteoporosis	2.29e-05	0.000311	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PGLS—osteoporosis	2.29e-05	0.000311	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PSMA5—osteoporosis	2.28e-05	0.000311	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PSMA2—osteoporosis	2.28e-05	0.000311	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CA2—osteoporosis	2.28e-05	0.000311	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—OXCT1—osteoporosis	2.28e-05	0.000311	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—OXCT1—osteoporosis	2.23e-05	0.000303	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CA2—osteoporosis	2.23e-05	0.000303	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MGLL—osteoporosis	2.22e-05	0.000303	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP27A1—osteoporosis	2.17e-05	0.000296	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MGLL—osteoporosis	2.17e-05	0.000296	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—MTHFR—osteoporosis	2.16e-05	0.000294	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—IDH2—osteoporosis	2.12e-05	0.000289	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ACP5—osteoporosis	2.11e-05	0.000288	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ENO1—osteoporosis	2.11e-05	0.000287	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—OXCT1—osteoporosis	2.1e-05	0.000286	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CA2—osteoporosis	2.1e-05	0.000286	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.1e-05	0.000286	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PNP—osteoporosis	2.09e-05	0.000285	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ATIC—osteoporosis	2.09e-05	0.000285	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.09e-05	0.000284	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—OXCT1—osteoporosis	2.08e-05	0.000283	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CA2—osteoporosis	2.08e-05	0.000283	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PSMA2—osteoporosis	2.08e-05	0.000283	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PSMA5—osteoporosis	2.08e-05	0.000283	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ADCY5—osteoporosis	2.05e-05	0.00028	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GPX1—osteoporosis	2.05e-05	0.000279	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MGLL—osteoporosis	2.04e-05	0.000279	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MGLL—osteoporosis	2.03e-05	0.000276	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.99e-05	0.000271	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—POMC—osteoporosis	1.97e-05	0.000269	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—TPI1—osteoporosis	1.96e-05	0.000268	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ACP5—osteoporosis	1.94e-05	0.000264	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.91e-05	0.000261	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.91e-05	0.00026	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—IDH2—osteoporosis	1.89e-05	0.000258	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—MTHFR—osteoporosis	1.89e-05	0.000257	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PKM—osteoporosis	1.86e-05	0.000254	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FDPS—osteoporosis	1.86e-05	0.000254	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP19A1—osteoporosis	1.85e-05	0.000252	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—P4HB—osteoporosis	1.85e-05	0.000252	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—IDH2—osteoporosis	1.84e-05	0.000251	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GAPDH—osteoporosis	1.81e-05	0.000247	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—TPI1—osteoporosis	1.8e-05	0.000245	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—OXCT1—osteoporosis	1.78e-05	0.000242	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CA2—osteoporosis	1.78e-05	0.000242	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.78e-05	0.000242	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—RAP1A—osteoporosis	1.77e-05	0.000241	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PGLS—osteoporosis	1.76e-05	0.00024	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPD2—osteoporosis	1.76e-05	0.00024	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—IDH2—osteoporosis	1.74e-05	0.000237	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP27A1—osteoporosis	1.73e-05	0.000236	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MGLL—osteoporosis	1.73e-05	0.000236	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ACP5—osteoporosis	1.73e-05	0.000236	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—POMC—osteoporosis	1.73e-05	0.000235	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—IDH2—osteoporosis	1.72e-05	0.000235	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.71e-05	0.000233	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.7e-05	0.000232	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.7e-05	0.000231	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—P4HB—osteoporosis	1.69e-05	0.000231	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ACP5—osteoporosis	1.69e-05	0.00023	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP19A1—osteoporosis	1.69e-05	0.00023	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GAPDH—osteoporosis	1.66e-05	0.000226	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.63e-05	0.000223	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.63e-05	0.000223	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.62e-05	0.000221	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—RAP1A—osteoporosis	1.62e-05	0.000221	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PNP—osteoporosis	1.61e-05	0.00022	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ATIC—osteoporosis	1.61e-05	0.00022	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TPI1—osteoporosis	1.61e-05	0.000219	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ACP5—osteoporosis	1.59e-05	0.000217	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.59e-05	0.000217	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.59e-05	0.000216	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ACP5—osteoporosis	1.58e-05	0.000215	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TPI1—osteoporosis	1.57e-05	0.000214	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.56e-05	0.000212	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.54e-05	0.00021	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ADCY5—osteoporosis	1.51e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—P4HB—osteoporosis	1.51e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—POMC—osteoporosis	1.51e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GPX1—osteoporosis	1.51e-05	0.000206	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GAPDH—osteoporosis	1.48e-05	0.000202	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TPI1—osteoporosis	1.48e-05	0.000201	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—P4HB—osteoporosis	1.47e-05	0.000201	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—IDH2—osteoporosis	1.47e-05	0.000201	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TPI1—osteoporosis	1.47e-05	0.0002	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GAPDH—osteoporosis	1.45e-05	0.000197	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—RAP1A—osteoporosis	1.44e-05	0.000197	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ENO1—osteoporosis	1.43e-05	0.000194	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.41e-05	0.000192	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—RAP1A—osteoporosis	1.41e-05	0.000192	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PSMA2—osteoporosis	1.41e-05	0.000192	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PSMA5—osteoporosis	1.41e-05	0.000192	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MTHFR—osteoporosis	1.39e-05	0.00019	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—P4HB—osteoporosis	1.39e-05	0.000189	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.38e-05	0.000189	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—P4HB—osteoporosis	1.38e-05	0.000188	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ADCY5—osteoporosis	1.38e-05	0.000188	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GPX1—osteoporosis	1.37e-05	0.000187	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—OXCT1—osteoporosis	1.37e-05	0.000187	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CA2—osteoporosis	1.37e-05	0.000187	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GAPDH—osteoporosis	1.36e-05	0.000186	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GAPDH—osteoporosis	1.35e-05	0.000184	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ACP5—osteoporosis	1.35e-05	0.000184	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MGLL—osteoporosis	1.34e-05	0.000182	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.33e-05	0.000181	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—RAP1A—osteoporosis	1.33e-05	0.000181	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—RAP1A—osteoporosis	1.32e-05	0.00018	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ENO1—osteoporosis	1.31e-05	0.000178	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000176	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000176	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTHFR—osteoporosis	1.27e-05	0.000173	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.26e-05	0.000172	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TPI1—osteoporosis	1.25e-05	0.000171	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—P4HB—osteoporosis	1.18e-05	0.00016	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ENO1—osteoporosis	1.17e-05	0.000159	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GAPDH—osteoporosis	1.16e-05	0.000158	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PSMA5—osteoporosis	1.15e-05	0.000157	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PSMA2—osteoporosis	1.15e-05	0.000157	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.15e-05	0.000157	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.14e-05	0.000155	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ENO1—osteoporosis	1.14e-05	0.000155	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—IDH2—osteoporosis	1.14e-05	0.000155	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—RAP1A—osteoporosis	1.13e-05	0.000153	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PSMA2—osteoporosis	1.12e-05	0.000153	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PSMA5—osteoporosis	1.12e-05	0.000153	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—POMC—osteoporosis	1.11e-05	0.000152	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ENO1—osteoporosis	1.07e-05	0.000146	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.07e-05	0.000146	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ENO1—osteoporosis	1.06e-05	0.000145	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PSMA2—osteoporosis	1.06e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PSMA5—osteoporosis	1.06e-05	0.000144	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PSMA5—osteoporosis	1.05e-05	0.000143	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PSMA2—osteoporosis	1.05e-05	0.000143	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.05e-05	0.000143	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ACP5—osteoporosis	1.04e-05	0.000142	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—osteoporosis	1.01e-05	0.000138	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.82e-06	0.000134	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TPI1—osteoporosis	9.66e-06	0.000132	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP19A1—osteoporosis	9.33e-06	0.000127	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ADCY5—osteoporosis	9.32e-06	0.000127	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX1—osteoporosis	9.29e-06	0.000127	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP19A1—osteoporosis	9.11e-06	0.000124	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ENO1—osteoporosis	9.1e-06	0.000124	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—P4HB—osteoporosis	9.09e-06	0.000124	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PSMA5—osteoporosis	8.97e-06	0.000122	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PSMA2—osteoporosis	8.97e-06	0.000122	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GAPDH—osteoporosis	8.92e-06	0.000122	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—RAP1A—osteoporosis	8.69e-06	0.000118	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.59e-06	0.000117	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—osteoporosis	8.57e-06	0.000117	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ADCY5—osteoporosis	8.55e-06	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—osteoporosis	8.52e-06	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP19A1—osteoporosis	8.51e-06	0.000116	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—osteoporosis	7.86e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ADCY5—osteoporosis	7.63e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—osteoporosis	7.6e-06	0.000104	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ADCY5—osteoporosis	7.44e-06	0.000101	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—osteoporosis	7.42e-06	0.000101	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP19A1—osteoporosis	7.27e-06	9.91e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ENO1—osteoporosis	7.02e-06	9.57e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ADCY5—osteoporosis	7.02e-06	9.56e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—osteoporosis	7.01e-06	9.56e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—osteoporosis	6.99e-06	9.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ADCY5—osteoporosis	6.95e-06	9.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—osteoporosis	6.93e-06	9.45e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PSMA2—osteoporosis	6.92e-06	9.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PSMA5—osteoporosis	6.92e-06	9.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—osteoporosis	6.86e-06	9.34e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—osteoporosis	6.85e-06	9.33e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—osteoporosis	6.45e-06	8.79e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—osteoporosis	6.4e-06	8.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—osteoporosis	6.29e-06	8.57e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADCY5—osteoporosis	5.94e-06	8.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—osteoporosis	5.92e-06	8.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.61e-06	7.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—osteoporosis	5.61e-06	7.65e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—osteoporosis	5.48e-06	7.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—osteoporosis	5.47e-06	7.45e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—osteoporosis	5.16e-06	7.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—osteoporosis	5.12e-06	6.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADCY5—osteoporosis	4.59e-06	6.25e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—osteoporosis	4.57e-06	6.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—osteoporosis	4.37e-06	5.96e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—osteoporosis	4.22e-06	5.75e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—osteoporosis	3.37e-06	4.6e-05	CbGpPWpGaD
